IPEK scientists revealed the role of two microRNAs called miR-126-3p and miR-126-5p in atherosclerosis. The results of the study are highly relevant for future approaches to the treatment of atherosclerosis. The therapeutic procedure already devised is the subject of a patent application, and its further development is underway at the German Center for Cardiovascular Research, in collaboration with interested biotechnology firms. Nature Medicine (2014)
The article MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1, Nature Medicine 2014, has been selected by Faculty of 1000 for F1000Prime. It was recommended as being of special significance in its field by Faculty Member Nanping Wang at http://f1000.com/prime/718293958?subscriptioncode=57c649de-ef79-48e3-becc-cea91ef7c019
Links:
http://www.uni-muenchen.de/forschung/news/forschung_2014/weber_atherosklerose.html
http://www.klinikum.uni-muenchen.de/de/0500aktuelles/aktuelles/140305_atherosklerose/index.html
http://www.en.uni-muenchen.de/news/newsarchiv/2014/weber_atherosclerosis.html
http://dzhk.de/dzhk-paper-of-the-month/paper-of-the-month/article/maerz-2014/
http://stm.sciencemag.org/content/6/230/230ec57
